313 related articles for article (PubMed ID: 15497855)
1. Removal of selected non-steroidal anti-inflammatory drugs (NSAIDs), gemfibrozil, carbamazepine, beta-blockers, trimethoprim and triclosan in conventional wastewater treatment plants in five EU countries and their discharge to the aquatic environment.
Paxéus N
Water Sci Technol; 2004; 50(5):253-60. PubMed ID: 15497855
[TBL] [Abstract][Full Text] [Related]
2. Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden.
Bendz D; Paxéus NA; Ginn TR; Loge FJ
J Hazard Mater; 2005 Jul; 122(3):195-204. PubMed ID: 15967274
[TBL] [Abstract][Full Text] [Related]
3. Occurrence and removal of pharmaceutically active compounds in sewage treatment plants with different technologies.
Ying GG; Kookana RS; Kolpin DW
J Environ Monit; 2009 Aug; 11(8):1498-505. PubMed ID: 19657534
[TBL] [Abstract][Full Text] [Related]
4. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment.
Radjenović J; Petrović M; Barceló D
Water Res; 2009 Feb; 43(3):831-41. PubMed ID: 19091371
[TBL] [Abstract][Full Text] [Related]
5. Removal of pharmaceuticals and fragrances in biological wastewater treatment.
Joss A; Keller E; Alder AC; Göbel A; McArdell CS; Ternes T; Siegrist H
Water Res; 2005 Sep; 39(14):3139-52. PubMed ID: 16043210
[TBL] [Abstract][Full Text] [Related]
6. Carbamazepine, diclofenac, ibuprofen and bezafibrate--investigations on the behaviour of selected pharmaceuticals during wastewater treatment.
Strenn B; Clara M; Gans O; Kreuzinger N
Water Sci Technol; 2004; 50(5):269-76. PubMed ID: 15497857
[TBL] [Abstract][Full Text] [Related]
7. Behavior of pharmaceuticals in waste water treatment plant in Japan.
Matsuo H; Sakamoto H; Arizono K; Shinohara R
Bull Environ Contam Toxicol; 2011 Jul; 87(1):31-5. PubMed ID: 21562834
[TBL] [Abstract][Full Text] [Related]
8. Removal of trace organic chemical contaminants by a membrane bioreactor.
Trinh T; van den Akker B; Stuetz RM; Coleman HM; Le-Clech P; Khan SJ
Water Sci Technol; 2012; 66(9):1856-63. PubMed ID: 22925856
[TBL] [Abstract][Full Text] [Related]
9. Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada.
Lishman L; Smyth SA; Sarafin K; Kleywegt S; Toito J; Peart T; Lee B; Servos M; Beland M; Seto P
Sci Total Environ; 2006 Aug; 367(2-3):544-58. PubMed ID: 16697441
[TBL] [Abstract][Full Text] [Related]
10. Occurrence of pharmaceutically active compounds during 1-year period in wastewaters from four wastewater treatment plants in Seville (Spain).
Santos JL; Aparicio I; Callejón M; Alonso E
J Hazard Mater; 2009 May; 164(2-3):1509-16. PubMed ID: 18990491
[TBL] [Abstract][Full Text] [Related]
11. Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants.
Clara M; Strenn B; Gans O; Martinez E; Kreuzinger N; Kroiss H
Water Res; 2005 Nov; 39(19):4797-807. PubMed ID: 16242170
[TBL] [Abstract][Full Text] [Related]
12. Occurrence and risk assessment of pharmaceutically active compounds in wastewater treatment plants. A case study: Seville city (Spain).
Santos JL; Aparicio I; Alonso E
Environ Int; 2007 May; 33(4):596-601. PubMed ID: 17084895
[TBL] [Abstract][Full Text] [Related]
13. Occurrence, partition and removal of pharmaceuticals in sewage water and sludge during wastewater treatment.
Jelic A; Gros M; Ginebreda A; Cespedes-Sánchez R; Ventura F; Petrovic M; Barcelo D
Water Res; 2011 Jan; 45(3):1165-76. PubMed ID: 21167546
[TBL] [Abstract][Full Text] [Related]
14. Removal of pharmaceuticals in secondary wastewater treatment processes in Taiwan.
Lin AY; Yu TH; Lateef SK
J Hazard Mater; 2009 Aug; 167(1-3):1163-9. PubMed ID: 19269086
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive assessment of the design configuration of constructed wetlands for the removal of pharmaceuticals and personal care products from urban wastewaters.
Hijosa-Valsero M; Matamoros V; Sidrach-Cardona R; Martín-Villacorta J; Bécares E; Bayona JM
Water Res; 2010 Jun; 44(12):3669-78. PubMed ID: 20494393
[TBL] [Abstract][Full Text] [Related]
16. Occurrence of several acidic drugs in sewage treatment plants in Switzerland and risk assessment.
Tauxe-Wuersch A; De Alencastro LF; Grandjean D; Tarradellas J
Water Res; 2005 May; 39(9):1761-72. PubMed ID: 15899274
[TBL] [Abstract][Full Text] [Related]
17. Removal of pharmaceutically active compounds in nitrifying-denitrifying plants.
Suárez S; Ramil M; Omil F; Lema JM
Water Sci Technol; 2005; 52(8):9-14. PubMed ID: 16312946
[TBL] [Abstract][Full Text] [Related]
18. Removal of cosmetic ingredients and pharmaceuticals in sewage primary treatment.
Carballa M; Omil F; Lema JM
Water Res; 2005 Nov; 39(19):4790-6. PubMed ID: 16246396
[TBL] [Abstract][Full Text] [Related]
19. Pharmaceutical chemicals and endocrine disrupters in municipal wastewater in Tokyo and their removal during activated sludge treatment.
Nakada N; Tanishima T; Shinohara H; Kiri K; Takada H
Water Res; 2006 Oct; 40(17):3297-303. PubMed ID: 16938339
[TBL] [Abstract][Full Text] [Related]
20. On the effect of pharmaceuticals on bacterial nitrite oxidation.
Dokianakis SN; Kornaros ME; Lyberatos G
Water Sci Technol; 2004; 50(5):341-6. PubMed ID: 15497867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
